$ECOR News
Last published 6d ago
- 6d agoECORelectroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewswireROCKAWAY, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord
- 1w agoECORelectroCore Third Quarter 2026 Earnings Call - ELECTROCORE INCEarnings Call TranscriptsGreetings, and welcome to the ElectroCorps Third Quarter 2026 Earnings Conference Call. At this time, all participants have been placed in listen-only mode. A question-and-answer session will follow the formal presentati
- 1w agoECORelectroCore Third Quarter 2026 Earnings Call - ELECTROCORE INCEarnings Call TranscriptsGreetings, and welcome to the ElectroCorps Third Quarter 2026 Earnings Conference Call. At this time, all participants have been placed in listen-only mode. A question-and-answer session will follow the formal presentati
- 1w agoECORelectroCore, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoECORelectroCore Announces Third Quarter 2026 Financial ResultsGlobeNewswireThird quarter 2026 net sales of $9.7 million, an increase of 12% over $8.7 million in the third quarter of 2025 Net loss of $1.3 million decreased 61% from prior year with Adjusted EBITDA net loss improving 67% from
- 1w agoECORelectroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026GlobeNewswireROCKAWAY, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report its financial results for the
- 2w agoECORPLANET MICROCAP TORONTO POWERED BY MICROCAPCLUB - ELECTROCORE INCEarnings Call Transcriptsout. Okay. Now presenting Joshua from Electric Core. Everyone, good morning. I don't think I need this, right? Good. It's good to see something. Oh, we're webcasting. So I do need this. We're webcasting. It is nice to se
- 2w agoECORELECTROCORE, INC. (NASDAQ: ECOR) - PLANET MICROCAP TORONTO - ELECTROCORE INCEarnings Call Transcriptsout. Okay. Now presenting Joshua from Electric Core. Everyone, good morning. I don't think I need this, right? Good. It's good to see something. Oh, we're webcasting. So I do need this. We're webcasting. It is nice to se
- 2w agoECORelectroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)GlobeNewswireROCKAWAY, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), ("electroCore" or the "Company"), a bioelectronic technology company, today announced that it has submitted a 510(k)
- 2w agoECORfMRI Study Suggests Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) Accelerates Neural Processes in Visual Skill LearningGlobeNewswireROCKAWAY, N.J.,, Oct. 27, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR) ("electroCore" or the "Company"), a commercial-stage bioelectronic medicine and wellness company, today announced
- 2w agoECORPlanet MicroCap 95 views 17 hours ago - ELECTROCORE INCEarnings Call TranscriptsWelcome to the Planet Microcap Podcast, the number one destination for everything microcap investing. I'm your host, Robert Kraft, and each week I sit down with elite investors, CEOs, and market experts to uncover action
- 3w agoECORelectroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClubGlobeNewswireROCKAWAY, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Toronto
- 2mo agoECORelectroCore to Participate at H.C. Wainwright Global Investment ConferenceGlobeNewswireROCKAWAY, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the H.C.
- 2mo agoECORelectroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive OfficersGlobeNewswireROCKAWAY, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company and leader in non-invasive vagus nerve stimulation technologies, today
- 2mo agoECORelectroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle AwardsGlobeNewswireROCKAWAY, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a bioelectronic technology company, today announced that Truvaga, its non-invasive vagus nerve stimulation (nVNS) wellness brand, has
- 3mo agoECORelectroCore Announces Second Quarter 2026 Financial ResultsGlobeNewswireSecond quarter 2026 net sales of $9.5 million, an increase of 28% over $7.4 million in the second quarter 2025 Net loss of $3.1 million decreased 17% from prior year with Adjusted EBITDA net loss improving 26% from
- 3mo agoECORelectroCore to Participate in Upcoming Investor ConferencesGlobeNewswireROCKAWAY, N.J., Aug. 03, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following
- 3mo agoECORelectroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026GlobeNewswireROCKAWAY, N.J., July 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the second
- 3mo agoECORNew Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve StimulationGlobeNewswireROCKAWAY, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company and leader in non-invasive vagus nerve stimulation technologies, today
- 4mo agoECORelectroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment ConferenceGlobeNewswireROCKAWAY, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will participate in the iAccess Alpha Virtual
- 5mo agoECORFrontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without SurgeryGlobeNewswireROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, "Without getting under
- 5mo agoECORelectroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClubGlobeNewswireROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas
- 6mo agoECORelectroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in FibromyalgiaGlobeNewswireROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in JAMA Network
- 6mo agoECORelectroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026GlobeNewswireROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the LD Micro
- 6mo agoECORelectroCore Announces First Quarter 2026 Financial ResultsGlobeNewswireFirst quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year period to $2.3 million
- 6mo agoECORelectroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero ChallengeGlobeNewswireROCKAWAY, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that TAC-STIM™, its non-invasive vagus nerve
- 6mo agoECORelectroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026GlobeNewswireROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the first
- 6mo agoECORelectroCore to Present at the Market Movers Investor Summit on May 5, 2026GlobeNewswireROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the Market Movers
- 6mo agoECORelectroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve StimulationGlobeNewswireROCKAWAY, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced its participation in Hacking the Vagus Nerve, a
- 7mo agoECORelectroCore to Participate in the 25th Annual Needham Virtual Healthcare ConferenceGlobeNewswireROCKAWAY, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham
- 7mo agoECORelectroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSDGlobeNewswireROCKAWAY, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the enrollment of the first eight patients in a
- 7mo agoECORelectroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSDGlobeNewswireROCKAWAY, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in Frontiers
- 7mo agoECORelectroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireROCKAWAY, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Seth Abrams will join
- 7mo agoECORelectroCore Expands Intellectual Property PortfolioGlobeNewswireROCKAWAY, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the issuance of two new U.S. patents that further
- 8mo agoECORelectroCore to Participate at the 38th Annual Roth ConferenceGlobeNewswireROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a bioelectronic medicine and wellness company, announced today that management will participate in the 38th Annual Roth Conference
- 8mo agoECORelectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026GlobeNewswireROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth
- 9mo agoECORAcacia Clinics and Vagus Nerve Society Conduct Study Using electroCore's gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder ("PTSD")GlobeNewswireROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR) ("electroCore" or the "Company"), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus Nerve Society
- 9mo agoECORelectroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 MillionGlobeNewswireRecord revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 Revenue growth of approximately 26% over full-year 2024Cash,
- 11mo agoECORTAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force AirmenGlobeNewswireROCKAWAY, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR) ("electroCore" or the "Company"), a bioelectronic technology company, today announced the publication of a peer reviewed paper titled
- 1y agoECORelectroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewswireROCKAWAY, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Canaccord
- 1y agoECORelectroCore Announces Third Quarter 2025 Financial ResultsGlobeNewswireNet sales of $8.7 million increased 33% vs. Q3 2024; YTD net sales of $22.8 million increased 26% vs. first nine months of 2024 Cash, cash equivalents, restricted cash, and marketable securities ("Total Cash") of $13.2
- 1y agoECORelectroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025GlobeNewswireROCKAWAY, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the third
- 1y agoECORelectroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireROCKAWAY, N.J., Oct. 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Jennifer Hayes will be joining
- 1y agoECORgammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion SymptomsGlobeNewswireROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer-reviewed study in Frontiers
- 1y agoECORelectroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in BelgiumGlobeNewswireROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc.
- 1y agoECORelectroCore's Truvaga™ Plus Named "Best Relaxation Gadget" in Esquire's 2025 Sleep AwardsGlobeNewswireROCKAWAY, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its Truvaga™ Plus handheld vagus nerve
- 1y agoECORelectroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireROCKAWAY, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Andy Brown has joined
- 1y agoECORelectroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the BoardGlobeNewswireROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from the Board of
- 1y agoECORelectroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress ReliefGlobeNewswireROCKAWAY, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its partnership with Greg Buttle, former New York Jets
- 1y agoECORelectroCore Appoints Elena Bonfiglioli to Board of DirectorsGlobeNewswireROCKAWAY, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Elena Bonfiglioli, an accomplished healthcare